The structure of pathogenic huntingtin exon-1 defines the bases of its aggregation propensity

No abstract is available for this paper.

• Publication year

  2022

• Venue

  bioRxiv

• Publication date

  2022-10-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/2022.10.25.513661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Huntingtin fibrils with different toxicity, structure, and seeding potential can be interconverted

  2021cited by this paper
• Huntington’s Disease: New Frontiers in Therapeutics

  2021cited by this paper
• Abrogation of prenucleation, transient oligomerization of the Huntingtin exon 1 protein by human profilin I

  2020cited by this paper
• Flanking Regions Determine the Structure of the Poly-Glutamine in Huntingtin through Mechanisms Common among Glutamine-Rich Human Proteins.

  2020cited by this paper
• Robust Cell-Free Expression of Sub-Pathological and Pathological Huntingtin Exon-1 for NMR Studies. General Approaches for the Isotopic Labeling of Low-Complexity Proteins

  2020cited by this paper
• Refining All-Atom Protein Force Fields for Polar-Rich, Prion-like, Low-Complexity Intrinsically Disordered Proteins.

  2020cited by this paper
• Realistic Ensemble Models of Intrinsically Disordered Proteins Using a Structure-Encoding Coil Database.

  2019cited by this paper
• Site‐Specific Isotopic Labeling (SSIL): Access to High‐Resolution Structural and Dynamic Information in Low‐Complexity Proteins

  2019cited by this paper
• Nanoscale organization of tetraspanins during HIV-1 budding by correlative dSTORM/AFM.

  2019cited by this paper
• Side chain to main chain hydrogen bonds stabilize a polyglutamine helix in a transcription factor

  2019cited by this paper
• The SCOP database in 2020: expanded classification of representative family and superfamily domains of known protein structures

  2019cited by this paper
• Probing initial transient oligomerization events facilitating Huntingtin fibril nucleation at atomic resolution by relaxation-based NMR

  2019cited by this paper
• Disentangling the complexity of low complexity proteins

  2019cited by this paper
• The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract

  2018cited by this paper
• Consensus Bayesian assessment of protein molecular mass from solution X-ray scattering data

  2018cited by this paper
• Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

  2018cited by this paper
• A General Strategy to Access Structural Information at Atomic Resolution in Polyglutamine Homorepeats

  2018cited by this paper
• Interaction of Huntingtin Exon-1 Peptides with Lipid-Based Micellar Nanoparticles Probed by Solution NMR and Q-Band Pulsed EPR.

  2018cited by this paper
• POTENCI: prediction of temperature, neighbor and pH-corrected chemical shifts for intrinsically disordered proteins

  2018cited by this paper
• Conformation Polymorphism of Polyglutamine Proteins.

  2018cited by this paper
• Emerging β-Sheet Rich Conformations in Supercompact Huntingtin Exon-1 Mutant Structures.

  2017cited by this paper
• CHROMIXS: automatic and interactive analysis of chromatography-coupled small-angle X-ray scattering data

  2017cited by this paper
• Huntingtin Inclusions Trigger Cellular Quiescence, Deactivate Apoptosis, and Lead to Delayed Necrosis.

  2017cited by this paper
• Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core

  2017cited by this paper
• Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract

  2016cited by this paper
• Nanoscale studies link amyloid maturity with polyglutamine diseases onset

  2016cited by this paper
• Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer

  2016cited by this paper
• Soluble Oligomers of PolyQ-Expanded Huntingtin Target a Multiplicity of Key Cellular Factors.

  2016cited by this paper
• The Biology of Huntingtin.

  2016cited by this paper
• Huntingtin exon 1 fibrils feature an interdigitated β-hairpin–based polyglutamine core

  2016cited by this paper
• Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering

  2015cited by this paper
• Versatile sample environments and automation for biological solution X-ray scattering experiments at the P12 beamline (PETRA III, DESY)

  2015cited by this paper
• Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation

  2015cited by this paper
• Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1.

  2015cited by this paper
• Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties.

  2012cited by this paper
• Multiple-site labeling of proteins with unnatural amino acids.

  2012cited by this paper
• Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

  2012cited by this paper
• Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins.

  2010cited by this paper
• SPARTA+: a modest improvement in empirical NMR chemical shift prediction by means of an artificial neural network

  2010cited by this paper
• Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease

  2009cited by this paper
• Cell-free protein synthesis for analysis by NMR spectroscopy.

  2008cited by this paper
• Oligoproline effects on polyglutamine conformation and aggregation.

  2006cited by this paper
• Critical Role of the Proline-rich Region in Huntingtin for Aggregation and Cytotoxicity in Yeast*

  2006cited by this paper
• Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin.

  2006cited by this paper
• Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

  2005cited by this paper
• The CCPN data model for NMR spectroscopy: Development of a software pipeline

  2005cited by this paper
• Finite optical spot size and position corrections in thermal spring constant calibration

  2004cited by this paper
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004cited by this paper
• Beyond the Qs in the polyglutamine diseases.

  2001cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats.

  1994cited by this paper
• Huntington's disease

  1984cited by this paper

• Transient tertiary structure in intrinsically disordered proteins revealed by multithermal enhanced sampling

  2026cites this paper
• A coarse‐grained model for disordered and multi‐domain proteins

  2024cites this paper
• Transient interdomain interactions modulate the monomeric structural ensemble and self-assembly of Huntingtin Exon 1

  2024cites this paper
• Quantifying surface tension and viscosity in biomolecular condensates by FRAP-ID

  2024cites this paper
• Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal

  2023cites this paper
• Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal

  2023cites this paper
• A glutamine-based single α-helix scaffold to target globular proteins

  2022cites this paper